Found: 17
Select item for more details and to access through your institution.
Extending the scope of amantadine drug by incorporation of phenolic azo Schiff bases as potent selective inhibitors of carbonic anhydrase II, drug‐likeness and binding analysis.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1692, doi. 10.1111/cbdd.13335
- By:
- Publication type:
- Article
Pyrimidine‐based pyrazoles as cyclin‐dependent kinase 2 inhibitors: Design, synthesis, and biological evaluation.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1683, doi. 10.1111/cbdd.13334
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2018
- Publication type:
- Correction Notice
Design, synthesis and evaluation of a novel series of inhibitors reversing P‐glycoprotein‐mediated multidrug resistance.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1708, doi. 10.1111/cbdd.13338
- By:
- Publication type:
- Article
Computational investigation on the binding modes of Rimonabant analogs with CB1 and CB2.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1699, doi. 10.1111/cbdd.13337
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- 2018
- By:
- Publication type:
- Cover Art
Corrigendum.
- Published in:
- 2018
- Publication type:
- Correction Notice
New 1,2,3‐triazole‐based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1670, doi. 10.1111/cbdd.13333
- By:
- Publication type:
- Article
Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum‐based compound.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1657, doi. 10.1111/cbdd.13332
- By:
- Publication type:
- Article
Synthesis and biological evaluation of novel N‐aryl‐ω‐(benzoazol‐2‐yl)‐sulfanylalkanamides as dual inhibitors of α‐glucosidase and protein tyrosine phosphatase 1B.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1647, doi. 10.1111/cbdd.13331
- By:
- Publication type:
- Article
Molecular basis of benzimidazole inhibitors to hepatitis C virus envelope glycoprotein.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1638, doi. 10.1111/cbdd.13329
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1597, doi. 10.1111/cbdd.13324
- By:
- Publication type:
- Article
Syntheses and evaluation of <sup>68</sup>Ga‐ and <sup>153</sup>Sm‐labeled DOTA‐conjugated bisphosphonate ligand for potential use in detection of skeletal metastases and management of pain arising from skeletal metastases.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1618, doi. 10.1111/cbdd.13327
- By:
- Publication type:
- Article
Hydrocortisone inhibition of wild‐type and αD200Q nicotinic acetylcholine receptors.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1610, doi. 10.1111/cbdd.13325
- By:
- Publication type:
- Article
Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1627, doi. 10.1111/cbdd.13328
- By:
- Publication type:
- Article
Discovery of benzimidazole‐based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1585, doi. 10.1111/cbdd.13326
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1581, doi. 10.1111/cbdd.13100
- Publication type:
- Article